A phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with locally advanced rectal cancer (LARC): Long-term results | NobleID
v1
A phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with locally advanced rectal cancer (LARC): Long-term results
